Abstract
Some visionaries prefer to dream of immortality rather than to actually live longer. Here I discuss how combining rapamycin with other modalities may let us live long enough to benefit from future discoveries in cellular reprogramming and what needs to be done at Atlos Labs to make this happen.
Cite
CITATION STYLE
APA
Blagosklonny, M. V. (2022). Atlos Labs and the quest for immortality: but can we live longer right now? Oncoscience, 9, 13–16. https://doi.org/10.18632/oncoscience.552
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free